Immunovant, Inc. — SCHEDULE 13G/A Filings
2 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Immunovant, Inc. (IMVT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Immunovant, Inc. has filed 2 SCHEDULE 13G/A documents with the SEC since 2019. To view all SEC filings by Immunovant, Inc., see the full filings list.
All
10-K
10-Q
144
25-NSE
3
4
4/A
424B3
424B4
424B5
424B7
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
PRE 14A
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000315066-25-002737 | Nov 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000990 | Mar 7, 2025 | — |